Showing results (151-160 of 529) with videos related to

Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|December 24, 2024
Management of dyslipidaemia in patients with comorbidities-facing the challengeLisa Frühwald, Peter Fasching, Dobromir Dobrev, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 7, 2025
Expert opinion on the integration of combination therapy into the treatment algorithm for the management of dyslipidaemiaKlaus G Parhofer, Carlos Aguiar, Maciej Banach, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 9, 2024
Subcutaneous furosemide in heart failure: a systematic reviewJoanna Osmanska, Mark C Petrie, Kieran F Docherty, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 30, 2024
Incidence and outcomes of transient new-onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysisNadia Salerno, Jessica Ielapi, Angelica Cersosimo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 18, 2024
Design and baseline characteristics of the STRIDE trial: evaluating semaglutide in people with symptomatic peripheral artery disease and type 2 diabetesMarc P Bonaca, Andrei-Mircea Catarig, Yasemin Hansen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 24, 2024
An aspirin-free strategy for percutaneous coronary intervention in patients with diabetes: a pre-specified subgroup analysis of the STOPDAPT-3 trialKo Yamamoto, Masahiro Natsuaki, Hirotoshi Watanabe, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 9, 2025
Comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in atherosclerotic cardiovascular disease phenotypes: a systematic review and meta-analysisYu-Min Lin, Jheng-Yan Wu, Mei-Chuan Lee, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 17, 2024
Management of dyslipidaemia in patients with comorbidities: facing the challengeGert Mayer, Dobromir Dobrev, Juan Carlos Kaski, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 16, 2019
Switching from vitamin K antagonist to dabigatran in atrial fibrillation: differences according to doseNaja Emborg Vinding, Laila Staerk, Gunnar Hilmar Gislason, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 31, 2018
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularizationStefano Albani, Enrico Fabris, Sara Doimo, et al.
Pageof 53